Recombinant Sheep CRHR1 is synthesized in E. coli systems, yielding a 415-amino acid protein (residues 24–415) with an N-terminal His-tag for purification . Key specifications include:
| Property | Detail |
|---|---|
| UniProt ID | O62772 |
| Molecular Weight | ~45–50 kDa (glycosylation-dependent) |
| Purity | >90% (SDS-PAGE verified) |
| Storage | Lyophilized in Tris/PBS buffer with 6% trehalose (pH 8.0); -80°C stable |
| Reconstitution | Deionized water + 50% glycerol recommended for long-term storage |
The protein retains functional ligand-binding domains, enabling interaction with corticotropin-releasing hormone (CRH) and related peptides .
CRHR1 binds CRH with high affinity, initiating cAMP-dependent pathways that regulate ACTH secretion .
Structural studies of human CRHR1’s extracellular domain (ECD) reveal a conserved α-β-βα fold, though sheep CRHR1 exhibits a truncated N-terminal helix compared to human orthologs .
CRHR1 activation enhances neural stem cell self-renewal via the CREB/REST pathway, delaying neuronal differentiation in embryonic models .
Knockdown experiments show increased βIII-tubulin expression (neuronal marker), confirming CRHR1’s role in maintaining stemness .
KEGG: oas:443025
UniGene: Oar.759
Sheep CRHR1 is a seven-transmembrane helix, G-protein-coupled receptor encoded by a 1245 bp open reading frame that translates to a 415 amino acid protein . The receptor belongs to the GPCR superfamily and shares significant homology with CRHR1 from other species: 95% with human, 94% with mouse/rat, 86% with chicken, and 78% with xenopus CRHR1 . Structurally, the receptor contains an extracellular N-terminal domain responsible for ligand binding, seven transmembrane domains that anchor the receptor in the cell membrane, and a cytoplasmic tail region critical for signal transduction and receptor internalization.
CRHR1 serves as the primary receptor for corticotropin-releasing hormone (CRH) and also binds urocortin (UCN) with high affinity . Upon ligand binding, the receptor undergoes a conformational change that triggers signaling via guanine nucleotide-binding proteins (G proteins) . This activation primarily leads to:
Promotion of adenylate cyclase activity, resulting in increased intracellular cAMP levels
Inhibition of the calcium channel CACNA1H
Initiation of downstream signaling cascades affecting stress responses
CRHR1 is required for normal embryonic development of the adrenal gland and for appropriate hormonal responses to stress . The receptor plays a critical role in mediating anxiogenic responses and coordinating the body's physiological adaptation to stressors.
While sheep CRHR1 shares 95% homology with human CRHR1, there are notable differences :
| Species Comparison | Sequence Identity | Key Distinctions |
|---|---|---|
| Sheep vs. Human | 95% homology | Sheep CRHR1 shows selectivity for ovine CRF compared to human/rat CRF |
| Sheep vs. Rat | 94% homology | Differences in binding affinity and downstream signaling efficiency |
| Ovine CRF vs. Human/Rat CRF | 84% identity | Structural variations affecting receptor binding properties |
These differences may impact experimental design considerations when studying receptor pharmacology across species and when developing models for human disease states.
Research demonstrates that CRHR1 genetic variants modify stress responsivity and susceptibility to mental health disorders . Specific single nucleotide polymorphisms (SNPs) have been associated with altered stress responses:
The Rs242924 SNP shows significant association with mental health scores (OR=1.31-1.6, p<0.05) and vitality measures (OR=1.31-1.38, p<0.05) after stressful life events .
Rs7209436 and Rs110402 variants are linked to emotional regulation differences and stress resilience .
The interaction between Rs242939 and negative life events shows a cross-validation consistency of 10 and p-value of 0.023 after Bonferroni correction, suggesting gene-environment interactions in susceptibility to stress-related disorders .
CRHR1 minor genotypes may confer either vulnerability or resilience to stress-related psychopathology, depending on the specific variant and environmental context . This has implications for understanding individual variability in stress responses in both humans and animal models.
For successful recombinant expression of sheep CRHR1, consider these methodological guidelines:
Expression System Selection: Mammalian cell lines (typically HEK293 or CHO cells) are preferred over bacterial systems due to the requirement for proper post-translational modifications and membrane insertion .
Vector Design: Incorporate epitope tags (e.g., HA, FLAG) at the N-terminal domain to facilitate detection while avoiding interference with the C-terminal cytoplasmic tail, which is critical for G-protein coupling .
Transfection Protocol:
Transient transfection: Optimal for short-term experiments and binding assays
Stable transfection: Essential for long-term functional studies and consistent protein expression
Verification Methods:
Western blotting for protein expression
Immunocytochemistry for membrane localization
Radioligand binding assays to confirm functionality
To comprehensively evaluate the functional properties of recombinant sheep CRHR1, researchers should employ multiple complementary assays:
Ligand Binding Assays:
G-Protein Coupling Assessment:
Second Messenger Production:
Receptor Trafficking Studies:
Research has demonstrated that variants in the cytoplasmic tail of sheep CRHR1 can efficiently interact with Gαs but may fail to effectively stimulate G-protein activation of adenylate cyclase, highlighting the importance of comprehensive functional assessment .
Phylogenetic analyses of CRHR1 across vertebrates reveal important evolutionary insights:
Gene Duplication Events:
Conservation and Loss Patterns:
crh2 has been identified in holocephalan chondrichthyans, basal mammals, various sauropsids, and non-teleost actinopterygian holosteans
Recurrent independent losses of crh genes have occurred in various vertebrate lineages
crh1b is conserved in all teleosts studied, while crh1a has been lost independently in some species
Phylogenetic Relationships:
These evolutionary patterns provide context for understanding the functional conservation and species-specific adaptations of the CRHR1 system.
Researchers investigating the evolutionary history of CRHR1 employ several methodological approaches:
Sequence Analysis:
Phylogenetic Tree Construction:
Synteny Analysis:
Genome Mining:
These approaches allow researchers to reconstruct the complex evolutionary history of the CRHR1 gene family and understand the functional implications of evolutionary changes.
When investigating CRHR1 genetic variants, careful study design is essential:
SNP Selection Strategy:
Statistical Power Considerations:
Gene-Environment Interaction Analysis:
Quality Control Procedures:
Translating CRHR1 research findings across species presents several challenges:
Sequence and Structural Differences:
Signaling Pathway Variations:
Genetic Background Effects:
Differential genetic modifiers may influence CRHR1 function across species
Background strain effects in rodent models that may not translate to sheep or humans
Experimental Model Limitations:
Cell lines may not fully recapitulate the native receptor environment
Differences in post-translational modifications across expression systems
Researchers should account for these species-specific differences when designing experiments and interpreting results, particularly when attempting to translate findings to human clinical applications.
The cytoplasmic tail of sheep CRHR1 plays a critical role in signal transduction and receptor regulation:
G-Protein Coupling Efficiency:
Receptor Internalization Dynamics:
Signaling Pathway Selectivity:
The cytoplasmic domain may influence which downstream signaling pathways are activated
Alterations in this region can potentially shift signaling bias toward different effector mechanisms
Phosphorylation Sites:
The tail region contains multiple phosphorylation sites that regulate receptor desensitization and β-arrestin recruitment
Species-specific differences in these sites may influence receptor regulation
Understanding these mechanisms is essential for properly interpreting functional assays of recombinant CRHR1 and for designing experiments to investigate signaling pathway specificity.
Several promising research avenues warrant further investigation:
Structural Biology Approaches:
Cryo-EM or X-ray crystallography studies of sheep CRHR1 to elucidate species-specific binding pocket characteristics
Comparative structural analysis with human CRHR1 to identify critical functional domains
Genetic Editing Technologies:
CRISPR-Cas9 approaches to generate precise CRHR1 variants modeling human polymorphisms
Creation of humanized receptor models in sheep to better translate pharmacological findings
Systems Biology Integration:
Comprehensive characterization of the CRHR1 interactome in sheep tissues
Network analysis of stress-responsive pathways downstream of CRHR1 activation
Translational Applications:
Development of sheep models for stress-related disorders based on CRHR1 genetic variants
Testing of novel CRHR1-targeted therapeutics in physiologically relevant sheep models